Magenta Medical, the heart failure solutions developer based on proprietary miniaturized blood pump technology announced they have raised funds Monday in a round led by global venture capital firm New Enterprise Associates (NEA.) No financial details of the round were disclosed, but the round is said to be NEA’s first-ever life sciences investment in Israel, […]

The AI medical imaging analytics company has nabbed its third FDA clearance for an AI alert for intracranial hemorrhage (ICH) based on head CT scans.

The Israeli startup received clearance for an AI-powered system called HealthPNX, which alerts radiologists of pneumothorax, also known as a collapsed lung.

Teva's is the first generic naloxone hydrochloride nasal spray approved by the FDA.

Following approval by the FDA in the United States, the creators of the ReWalk exoskeleton, ARGO Medical Technologies' IPO shot up to $50 million dollars in worth almost overnight. Find out why this revolutionary system is putting the conventional wheelchair to shame.

Oramed Pharmaceuticals is in the process of developing insulin pills for the treatment of diabetes. The company is enetring a phase 2 clinical trial in the U.S and hoping to deliver the pills to the market by 2016.

Israeli bio-pharmaceutical company Kamada announced that it has obtained FDA approval to conduct a clinical trial in the US for the company’s next generation drug for the treatment of cystic fibrosis. The drug is an inhalable version of company’s AAT drug (Alpha-1 Antitrypsin deficiency). The current FDA approval is partly based on successful pre-clinical trials of the […]

Teva Respiratory, the U.S.-based respiratory subsidiary of Israeli Teva Pharmaceutical Industries announced that the FDA has approved its quick relief inhaler ProAir HFA with a dose counter, for the treatment or prevention of breathing disorders in patients four years of age and older. The dose counter is designed to help patients suffering drom disorders such […]

Israeli biotechnology company Thrombotech has obtained US Food and Drug Administration (FDA) approval for a Phase IIa clinical trial of its treatment for ischemic stroke by destroying blood clots. The trial will be conducted in the US and will test the safety of the drug, THR-18. The clinical trial was initiated at Hadassah Medical Center […]

Can-Fite BioPharma obtained US Food and Drug Administration (FDA) Orphan Drug Status for CF102 – a drug for primary liver cancer (hepatocellular carcinoma.) The drug was found to be safe in preclinical and Phase I clinical trials. Orphan Drug Status is granted for drugs being developed for the treatment of diseases that affect a small […]